Emmaus Life Sciences Receives Endari® Marketing Authorization from the Qatar Ministry of Public Health

Company Receives First Major Purchase Order in Saudi Arabia

TORRANCE, Calif., Nov. 17, 2022 /PRNewswire/ — Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, announced today that it has been issued a Registration Certificate from the Registration Committee for Pharmaceutical Companies & their Products of the Qatar Ministry of Public Health granting marketing authorization for the commercial distribution…